Drug Shortages

Below is a list of current and anticipated ophthalmic drug shortages. This table is generated from Health Canada and is intended for use by practicing ophthalmologists. Drugs that have been out of production or unavailable for more than 12 months are not included in this table.

The table is updated daily.

Submission to Health Canada’s Consultation on Improving Access to Drugs and Other Health Products

Ophthalmic Essential Medication List for Canada

Last Updated: 2024-03-18 00:01:28

Drug Name Drug Status Last Updated DIN Type Anticipated Start Date Estimated End Date Actual Start Date Actual End Date Shortage Reason
MED-BRIMONIDINE Marketed 2020-12-09 02507811 Shortage 2022-08-01 2022-11-15 2022-08-08 Demand increase for the drug.
OXERVATE Dormant 2022-05-08 02485613 Shortage 2023-08-30 Other (Please describe in comments)
OXERVATE Dormant 2022-05-08 02485613 Shortage 2023-08-30 Other (Please describe in comments)
APO-DICLOFENAC OPHTHALMIC Marketed 2023-12-19 02441020 Shortage 2023-07-11 Disruption of the manufacture of the drug.
DIOFLUOR STRIPS Marketed 2023-11-16 02160773 Shortage 2020-12-01 2021-03-22 Disruption of the manufacture of the drug.
ACT LATANOPROST/TIMOLOL Marketed 2024-02-09 02436256 Shortage 2021-08-27 Disruption of the manufacture of the drug.
ALOMIDE Marketed 2024-02-09 00893560 Shortage 2024-01-24 2024-04-05 2024-01-24 Demand increase for the drug.
APO-TIMOP Marketed 2018-03-08 00755834 Shortage 2024-01-02 Disruption of the manufacture of the drug.
ATROPINE Marketed 2024-02-09 02023695 Shortage 2020-11-01 Delay in shipping of the drug.
CYCLOGYL Marketed 2024-02-09 00252506 Shortage 2022-11-08 2024-06-30 2022-11-08 Requirements related to complying with good manufacturing practices.
FUCITHALMIC Marketed 2020-04-03 02243862 Shortage 2024-03-31 2023-12-14 Other (Please describe in comments)
JAMP-MOXIFLOXACIN Marketed 2024-03-09 02472120 Shortage 2024-06-30 2023-10-16 Disruption of the manufacture of the drug.
JAMP-OLOPATADINE Marketed 2024-02-09 02458411 Shortage 2024-06-30 2023-08-24 Other (Please describe in comments)
LATANOPROST AND TIMOLOL OPHTHALMIC SOLUTION Marketed 2022-06-08 02489368 Shortage 2023-06-26 Demand increase for the drug.
MINT-DICLOFENAC Dormant 2020-04-03 02475197 Shortage 2023-10-30 2023-03-27 Disruption of the manufacture of the drug.
MINT-DICLOFENAC Dormant 2020-04-03 02475197 Shortage 2023-10-30 2023-03-27 Disruption of the manufacture of the drug.
MIOCHOL-E Marketed 2021-12-08 02133326 Shortage 2023-12-10 2024-05-05 2023-11-08 Requirements related to complying with good manufacturing practices.
OCUFLOX Marketed 2024-03-09 02143291 Shortage 2024-02-10 2024-03-29 Demand increase for the drug.
SANDOZ MOXIFLOXACIN Marketed 2020-04-03 02411520 Shortage 2024-03-15 2024-03-11 Delay in shipping of the drug.
SOFRACORT Marketed 2024-03-09 02224623 Shortage 2023-08-28 2023-08-28 Other (Please describe in comments)
TEVA-CYCLOSPORINE Marketed 2024-03-09 02462486 Shortage 2024-03-20 2023-12-06 Disruption of the manufacture of the drug.
TEVA-LATANOPROST Marketed 2024-02-09 02254786 Shortage 2024-05-10 2024-02-07 Disruption of the manufacture of the drug.
TIMOLOL MALEATE-EX Marketed 2023-12-19 02242276 Shortage 2024-04-26 2023-12-19 Disruption of the manufacture of the drug.
VISTITAN Marketed 2024-03-09 02429063 Shortage 2024-06-21 2024-03-05 Shortage of an active ingredient.

- Minimize

+ Maximize

:
: